References
- Cuadros DF, Branscum AJ, Mukandavire Z, Miller FD, MacKinnon N. Dynamics of the COVID-19 epidemic in urban and rural areas in the United States. Ann Epidemiol 2021;59:16-20.
- Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020;38:1504-7.
- Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and cardiovascular disease. Circulation 2020;141:1648-55.
- Di Fusco M, Shea KM, Lin J, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ 2021;24:308-17.
- Talanas G, Dossi F, Parodi G. Type 2 myocardial infarction in patients with coronavirus disease 2019. J Cardiovasc Med (Hagerstown) 2021;22:603-5.
- Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020;5:802-10.
- Lala A, Johnson KW, Januzzi JL, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol 2020;76:533-46.
- Saaby L, Poulsen TS, Diederichsen AC, et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med 2014;127:295-302.
- Chapman AR, Shah AS, Lee KK, et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation 2018;137:1236-45.
- White K, Kinarivala M, Scott I. Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis. BMJ Open 2022;12:e055755.
- Sattar Y, Taha A, Patel N, et al. Cardiovascular outcomes of type 2 myocardial infarction among COVID-19 patients: a propensity matched national study. Expert Rev Cardiovasc Ther 2023;21:365-71.
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation 2018;138:e618-51.
- Weber B, Siddiqi H, Zhou G, et al. Relationship between myocardial injury during index hospitalization for SARS-CoV-2 infection and longer-term outcomes. J Am Heart Assoc 2022;11:e022010.
- Sandoval Y, Januzzi JL Jr, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol 2020;76:1244-58.
- Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is it all about endothelial dysfunction and thrombosis formation? The secret of COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211042940.
- Kwok CS, Gale CP, Kinnaird T, et al. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart 2020;106:1805-11.
- DeFilippis AP, Chapman AR, Mills NL, et al. Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation 2019;140:1661-78.
- Fox ER, Stolbach AI, Mazer-Amirshahi M. The landscape of prescription drug shortages during the COVID-19 pandemic. J Med Toxicol 2020;16:311-3.
- De Luca G, Verdoia M, Cercek M, et al. Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI. J Am Coll Cardiol 2020;76:2321-30.
- Sun C, Dyer S, Salvia J, Segal L, Levi R. Worse cardiac arrest outcomes during the COVID-19 pandemic in boston can be attributed to patient reluctance to seek care. Health Aff (Millwood) 2021;40:886-95.
- Raudenska J, Steinerova V, Javurkova A, et al. Occupational burnout syndrome and post-traumatic stress among healthcare professionals during the novel coronavirus disease 2019 (COVID-19) pandemic. Best Pract Res Clin Anaesthesiol 2020;34:553-60.
- Ohsfeldt RL, Choong CK, Mc Collam PL, Abedtash H, Kelton KA, Burge R. Inpatient hospital costs for COVID-19 patients in the United States. Adv Ther 2021;38:5557-95.
- McCarthy CP, Kolte D, Kennedy KF, Vaduganathan M, Wasfy JH, Januzzi JL Jr. Patient characteristics and clinical outcomes of type 1 versus type 2 myocardial infarction. J Am Coll Cardiol 2021;77:848-57.
- McCarthy CP, Murphy S, Cohen JA, et al. Underutilization of cardiac rehabilitation for type 2 myocardial infarction. J Am Coll Cardiol 2019;73:2005-7.
- Nazir S, Minhas AM, Kamat IS, et al. Patient characteristics and outcomes of type 2 myocardial infarction during heart failure hospitalizations in the United States. Am J Med 2021;134:1371-1379.e2.